# Correction to: “Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension”

PMC · DOI: 10.1210/clinem/dgag021 · The Journal of Clinical Endocrinology and Metabolism · 2026-01-28

## Full-text entities

- **Diseases:** hypoparathyroidism (MESH:D007011)
- **Chemicals:** palopegteriparatide (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13017021/full.md

---
Source: https://tomesphere.com/paper/PMC13017021